Viewing Study NCT02468232

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 9:27 PM
Ignite Modification Date: 2026-06-30 @ 2:49 AM
Study NCT ID: NCT02468232
Status: COMPLETED
Last Update Posted: 2023-12-08
First Post: 2015-06-08
Is NOT Gene Therapy: True
Has Adverse Events: True
Brief Title: Study of Efficacy and Safety of LCZ696 in Japanese Patients With Chronic Heart Failure and Reduced Ejection Fraction
Sponsor: Novartis Pharmaceuticals
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Heart Failure With Reduced Ejection Fraction (HF-rEF) View
Keywords:

Keywords

Keyword Brief Keyword Text View
None chronic heart failure View
None cardiovascular death View
None hospitalization View
None outcome study View
None worsening heart failure View
None NT-proBNP View
None NYHA View
None KCCQ View
None HF-rEF View